Clinical Aspects and Management of Levodopa-Induced Dyskinesia
Joint Authors
Cardaioli, Gabriela
Marsili, Erica
Tambasco, Nicola
Simoni, Simone
Calabresi, Paolo
Rossi, Aroldo
Sacchini, Elisa
Murasecco, Donatella
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2012-06-03
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Abstract EN
In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia.
After a few years, chronic treatment with levodopa is associated with the development of dyskinesias.
Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists.
Dopamine agonists with different pharmacological profile are available.
Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists.
American Psychological Association (APA)
Tambasco, Nicola& Simoni, Simone& Marsili, Erica& Sacchini, Elisa& Murasecco, Donatella& Cardaioli, Gabriela…[et al.]. 2012. Clinical Aspects and Management of Levodopa-Induced Dyskinesia. Parkinson’s Disease،Vol. 2012, no. 2012, pp.1-12.
https://search.emarefa.net/detail/BIM-1002819
Modern Language Association (MLA)
Tambasco, Nicola…[et al.]. Clinical Aspects and Management of Levodopa-Induced Dyskinesia. Parkinson’s Disease No. 2012 (2012), pp.1-12.
https://search.emarefa.net/detail/BIM-1002819
American Medical Association (AMA)
Tambasco, Nicola& Simoni, Simone& Marsili, Erica& Sacchini, Elisa& Murasecco, Donatella& Cardaioli, Gabriela…[et al.]. Clinical Aspects and Management of Levodopa-Induced Dyskinesia. Parkinson’s Disease. 2012. Vol. 2012, no. 2012, pp.1-12.
https://search.emarefa.net/detail/BIM-1002819
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1002819